Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | oxoproline | 29559 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
GC POSITIVE ION MODE | oxoproline | 51220 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | oxoproline | 67070 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | oxoproline | 77015 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | oxoproline | 82010 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | oxoproline | 87685 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | oxoproline | 90484 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 95175 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 96492 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 96954 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | oxoproline | 99507 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | oxoproline | 99928 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | oxoproline | 101958 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 113025 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | oxoproline | 114784 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 124348 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | oxoproline | 146971 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | oxoproline | 165996 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
GC POSITIVE ION MODE | oxoproline | 176384 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 176403 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | oxoproline | 178664 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | oxoproline | 192339 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 196110 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | oxoproline | 200357 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | oxoproline | 210815 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | oxoproline | 213701 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 234277 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | oxoproline | 235813 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
GC POSITIVE ION MODE | oxoproline | 252423 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 256323 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | oxoproline | 262689 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 262850 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | oxoproline | 267978 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 273627 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 275684 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 285905 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 287942 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 294547 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 300891 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 302406 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 302950 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 307017 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | oxoproline | 321233 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | oxoproline | 325183 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | oxoproline | 325950 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | oxoproline | 326088 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | oxoproline | 354887 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
GC POSITIVE ION MODE | oxoproline | 357448 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 373526 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
GC POSITIVE ION MODE | oxoproline | 373569 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | oxoproline | 373942 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 379503 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 393315 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | oxoproline | 407501 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | oxoproline | 424637 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | oxoproline | 460655 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 530227 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | oxoproline | 699905 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |